Skip to main content

HUM

Stock

HUM

Stock
Health Care
Healthcare Plans

Performance overview

HUM Price
Price Chart

Forward-looking statistics

Beta
0.61
Risk
40.21%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Company info

SectorHealth Care
IndustryHealthcare Plans
Employees57K
Market cap$42.4B

Fundamentals

Enterprise value$21.2B
Revenue$120.3B
Revenue per employee—
Profit margin1.42%
Debt to equity77.08

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$14.17
Dividend per share$3.54
Revenue per share$998.08
Avg trading volume (30 day)$394M
Avg trading volume (10 day)$360M
Put-call ratio—

Macro factor sensitivity

Growth+0.1
Credit+2.6
Liquidity-0.1
Inflation-2.2
Commodities-0.5
Interest Rates-0.8

Valuation

Dividend yield1.48%
PEG Ratio14.23
Price to sales0.24
P/E Ratio14.23
Enterprise Value to Revenue0.18
Price to book1.63

Upcoming events

Next earnings dayJuly 30, 2025
Next dividend day—
Ex. dividend dayJune 27, 2025

News

Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors

The latest trading day saw Humacyte, Inc. (HUMA) settling at $2.54, representing a -1.17% change from its previous close.

Zacks Investment Research (July 9, 2025)
Humana Expands Medicaid Footprint With Virginia's Cardinal Care Win

Cardinal Care taps HUM to offer its Healthy Horizons Medicaid plan, unlocking new growth in Virginia's healthcare market.

Zacks Investment Research (July 3, 2025)
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure

Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthcare companies aren't getting more investor respect despite their percentage of national output, and more.

CNBC Television (April 8, 2025)
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments

Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare Advantage plans run by private insurers.

Forbes (April 8, 2025)
Humana Earnings On Deck: Investors Brace For Slower Growth Clip

Health insurance company Humana HUM is set to release its fourth-quarter 2024 earnings report on Feb. 11, before market hours. The stock has dropped 2.37% from the previous close, as of writing, on Feb.10, according to Benzinga Pro.

Benzinga (February 10, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free